about
VE-statin/egfl7 expression in endothelial cells is regulated by a distal enhancer and a proximal promoter under the direct control of Erg and GATA-2Erg is a crucial regulator of endocardial-mesenchymal transformation during cardiac valve morphogenesisETS-related gene (ERG) controls endothelial cell permeability via transcriptional regulation of the claudin 5 (CLDN5) geneRhoJ is an endothelial cell-restricted Rho GTPase that mediates vascular morphogenesis and is regulated by the transcription factor ERG.Molecular mechanisms of endothelial differentiation.Vascular Stem/Progenitor Cell Migration and Differentiation in Atherosclerosis.Endothelial Cell Activation Is Regulated by Epidermal Growth Factor-like Domain 7 (Egfl7) during Inflammation.Transdifferentiated Human Vascular Smooth Muscle Cells are a New Potential Cell Source for Endothelial Regeneration.Adventitial SCA-1+ Progenitor Cell Gene Sequencing Reveals the Mechanisms of Cell Migration in Response to HyperlipidemiaA Cytokine-Like Protein Dickkopf-Related Protein 3 Is Atheroprotective.HIF-2alpha specifically activates the VE-cadherin promoter independently of hypoxia and in synergy with Ets-1 through two essential ETS-binding sites.ERG is required for the differentiation of embryonic stem cells along the endothelial lineage.Adventitial Sca1+ Cells Transduced With ETV2 Are Committed to the Endothelial Fate and Improve Vascular Remodeling After Injury.Leptin Induces Sca-1+ Progenitor Cell Migration Enhancing Neointimal Lesions in Vessel-Injury Mouse Models.Interventional cardiology: 3D printing of personalized implants for left atrial appendage occlusion.Basic research: Epigenetic map of heart development and disease.Public health: Light smoking and CVD risk.Basic research: Visceral adipose tissue regulates cardiac ageing.[Genes that make the endothelial identity].Smooth muscle cells differentiated from mesenchymal stem cells are regulated by microRNAs and suitable for vascular tissue grafts.Lipoprotein(a) is an independent predictor of CVDGWAS identifies new blood lipid-associated genetic variantsBasic research: RNA deadenylation by CCR4-NOT controls heart functionRisk factors: Mental stress puts women's hearts at riskHeart failure: BMP9 is an inhibitor of cardiac fibrosisHypertension: Benefit of BP self-monitoring for hypertensionInflammation: Pericardial adipose tissue regulates granulopoiesisHypertension: Hypertension intervention at the barbershopCholesterol-dependent inflammasome activation accelerates atherosclerosisDynamics of fibroblast activation in the infarcted heartExosome-based therapy to repair the injured heartTANNylated proteins target the heartRadial-artery versus saphenous-vein graftsGenetic variation explains residual CHD risk with statin therapyPublisher Correction: Exosome-based therapy to repair the injured heartDrug-eluting stents versus bare-metal stents for vein-graft PCIChronotherapy for atherosclerosisBinding of Dickkopf-3 to CXCR7 Enhances Vascular Progenitor Cell Migration and Degradable Graft RegenerationAAA: to screen or not to screen?ROBO4 variants linked to congenital heart defects
P50
Q21136180-2F66BB04-9843-44AC-9B2D-38E6EFEC1183Q28586764-4AACF335-0B6A-43CD-AFC5-94D63DBA19BFQ28771716-66AB9D9A-FDCE-4C44-9943-3D72C30761E8Q33917875-13CEE677-4EB9-4F44-9E80-FF9764E77C8BQ37771779-2357C7A7-D073-4C40-B5DF-D7439E28AD10Q38679917-8D797FEE-49A3-4A19-9CBA-1150B360D487Q40533421-EA027E8E-ACF9-40EF-8ADC-E55B2A964523Q41038639-227269AC-F903-4976-8CC7-DEC6D87DB53FQ41326807-5784DCFB-4C11-44CF-B767-FEA262D9BF2DQ42073870-9B936165-DCC5-4025-9146-0D979280FC33Q42513989-69ED18AC-A4A6-411C-9840-BD87DE06F0D8Q42940914-76BF80BA-7873-460A-B124-72FB972790D5Q47345012-774D2201-6169-4015-B307-BCA503E9F502Q47764682-9209F133-9BCE-4781-876D-62AB24904316Q49970892-DA088E9B-BB6D-4B3A-9125-256792DD43BCQ49985556-8F5405CA-D6FE-4DC0-9DB4-B425F289DC77Q50055110-F69E17CF-0E1D-4C2D-A869-AA7C37D8FD33Q51760661-3D474ABF-8BAA-4664-89DE-2BBC5DC4072AQ54738863-0DA949F6-DC67-4037-BAF8-BFF57978B68BQ55297965-E47B7E38-1D81-4114-866C-28E57D3C50CEQ58090274-1FE1732D-27A7-4414-857C-E4425EACDD58Q58115638-CB313CA6-234E-4CE4-B5FB-C291E9DD1777Q87842509-0E5964EB-7C21-457B-B3A8-EF3EB6861027Q88037075-FE468C2B-6DC1-4F6C-A9A3-6BEC05431DDAQ88064906-93A49A76-8EDF-4546-B138-B48FDA467051Q88064911-230D5FBD-9883-4E92-AB36-96FEB085B377Q88064914-DDE2E636-0589-4A90-9775-2ADA26614D19Q88205498-276FBC7C-A00B-40C4-9D95-2FB4DC7DB1B1Q88414710-55B45355-28F0-4AF1-8F41-77EAB91BFE81Q88524795-E9FC7AB3-EDFC-45EE-8B34-4C83318BB36FQ88634181-3625E75D-B58E-4D07-8655-E915D77DAE80Q88732871-FB326579-439E-4364-B12C-113501642ABBQ88732873-B8CEDC24-5173-42C9-AF53-9BEA88EADDC0Q88732876-1EF1A013-5366-44FE-A7EF-3FC44620D8CDQ88778694-AF107BE9-DA04-4142-9BCD-5E038044B2C4Q88985611-8AAB1031-4D63-4F28-8028-3E18DA69ACA1Q89181485-8486BC88-21E2-4ECE-90DE-E82FE8D055D9Q89449201-5DF547CC-AD24-4AC6-8458-B65DE0296FC2Q89450235-B8743C51-FA58-4B45-900B-551EDDD6F41AQ90371060-ADC45C15-1A67-42BD-AF32-6E8CBD1214E7
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Alexandra Le Bras
@ast
Alexandra Le Bras
@en
Alexandra Le Bras
@es
Alexandra Le Bras
@nl
Alexandra Le Bras
@sl
type
label
Alexandra Le Bras
@ast
Alexandra Le Bras
@en
Alexandra Le Bras
@es
Alexandra Le Bras
@nl
Alexandra Le Bras
@sl
altLabel
Alex Le Bras
@en
prefLabel
Alexandra Le Bras
@ast
Alexandra Le Bras
@en
Alexandra Le Bras
@es
Alexandra Le Bras
@nl
Alexandra Le Bras
@sl
P106
P21
P2798
P31
P496
0000-0001-7898-4618